Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging–Based Internal Dosimetry

Andrew R. Prideaux, Hong Song, Robert F. Hobbs, Bin He, Eric C. Frey, Paul W. Ladenson, Richard L. Wahl and George Sgouros
Journal of Nuclear Medicine June 2007, 48 (6) 1008-1016; DOI: https://doi.org/10.2967/jnumed.106.038000
Andrew R. Prideaux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Song
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert F. Hobbs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bin He
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric C. Frey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul W. Ladenson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Wahl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Sgouros
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Uniform-density sphere with effective half-life of 2 h in outer green region and 4 h within red region. Green and red regions have equal volume in this example. Initial activity in each region is selected so that total numbers of decays are equal in both regions.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Density distribution (uniform) (A) for uniform activity distribution model (B) and nonuniform activity distribution model (C). In nonuniform distribution, same total activity as shown in Figure 3B is concentrated into half the volume (outer shell). Assuming a uniform density sphere (A), 2 activity distributions are depicted: uniform (B) and nonuniform (C). In C, the same total activity as in B is concentrated into the outer shell of the sphere.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    (A) Spheric nonuniform density model in which inner sphere is twice unit density (2.0 g/cm3) and outer shell is at unit density (1.0 g/cm3). (B) Uniform activity distribution for density model in Figure 2A. (C) Cross-sectional slice of 3D-RD output for spheric nonuniform density model.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    (A) Clinical CT portion of a SPECT/CT scan of patient showing nonuniform density distribution in lungs. (B) Clinical SPECT scan of patient showing nonuniform activity distribution. (C) Rate map generated from 3 longitudinally aligned SPECT images; regions with effective half-life greater than physical half-life of 131I reflect tumor uptake. (D) Cumulative activity generated from rate map and SPECT.

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    Comparison between MCNP-based dose volume histogram of Song et al. (32) over lung and tumor regions and results from EGS using same inputs. Mean value of MCNP method is 3.01 × 10−5 mGy/MBq-s per pixel, whereas EGS mean is 2.88 × 10−5 mGy/MBq-s per pixel.

  • FIGURE 6. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6. 

    BED map resulting from 3D-RD using full patient-specific data. Although values of absorbed dose and BED are different, their relative changes from voxel to voxel are so similar that it is nearly impossible to visually differentiate the two.

  • FIGURE 7. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7. 

    Differential absorbed dose (solid line) and BED (dashed line) volume histograms of tumor (A) and of lung (B) resulting from full patient-specific 3D-RD calculation.

Tables

  • Figures
    • View popup
    TABLE 1

    Radiobiologic Parameters Used in Clinical 3D-RD Calculation

    Siteα (Gy−1)β (Gy−2)μ (h−1)
    Lung0.01720.005211.5
    Tumor0.3650.0281.3
    • View popup
    TABLE 2

    Summary of Results from Clinical 3D-RD Calculation

    ParameterTumor (Gy)Lungs (Gy)
    Mean absorbed dose57.79.5
    Mean BED58.59.8
    EUD25.08.3
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 48 (6)
Journal of Nuclear Medicine
Vol. 48, Issue 6
June 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging–Based Internal Dosimetry
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging–Based Internal Dosimetry
Andrew R. Prideaux, Hong Song, Robert F. Hobbs, Bin He, Eric C. Frey, Paul W. Ladenson, Richard L. Wahl, George Sgouros
Journal of Nuclear Medicine Jun 2007, 48 (6) 1008-1016; DOI: 10.2967/jnumed.106.038000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Three-Dimensional Radiobiologic Dosimetry: Application of Radiobiologic Modeling to Patient-Specific 3-Dimensional Imaging–Based Internal Dosimetry
Andrew R. Prideaux, Hong Song, Robert F. Hobbs, Bin He, Eric C. Frey, Paul W. Ladenson, Richard L. Wahl, George Sgouros
Journal of Nuclear Medicine Jun 2007, 48 (6) 1008-1016; DOI: 10.2967/jnumed.106.038000
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
  • Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
  • PARaDIM: A PHITS-Based Monte Carlo Tool for Internal Dosimetry with Tetrahedral Mesh Computational Phantoms
  • Three-Dimensional Dosimetry for Radiation Safety Estimates from Intrathecal Administration
  • Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer
  • Radioiodine Scintigraphy with SPECT/CT: An Important Diagnostic Tool for Thyroid Cancer Staging and Risk Stratification
  • Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging
  • Study of the Impact of Tissue Density Heterogeneities on 3-Dimensional Abdominal Dosimetry: Comparison Between Dose Kernel Convolution and Direct Monte Carlo Methods
  • Radioiodine Scintigraphy with SPECT/CT: An Important Diagnostic Tool for Thyroid Cancer Staging and Risk Stratification
  • Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma
  • Dosimetry and thyroid cancer: the individual dosage of radioiodine
  • Methodology to Incorporate Biologically Effective Dose and Equivalent Uniform Dose in Patient-Specific 3-Dimensional Dosimetry for Non-Hodgkin Lymphoma Patients Targeted with 131I-Tositumomab Therapy
  • The Monte Carlo Method in Nuclear Medicine: Current Uses and Future Potential
  • Arterial Wall Dosimetry for Non-Hodgkin Lymphoma Patients Treated with Radioimmunotherapy
  • Hybrid SPECT/CT: the end of "unclear" medicine
  • 124I PET-Based 3D-RD Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison
  • SPECT/CT
  • Google Scholar

More in this TOC Section

  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire